Financial Comparison: William Demant (WILYY) vs. Its Competitors

William Demant (OTCMKTS: WILYY) is one of 26 public companies in the “Surgical appliances & supplies” industry, but how does it weigh in compared to its competitors? We will compare William Demant to similar companies based on the strength of its dividends, valuation, earnings, analyst recommendations, risk, profitability and institutional ownership.

Analyst Recommendations

How to Become a New Pot Stock Millionaire

This is a summary of current ratings and target prices for William Demant and its competitors, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
William Demant 1 1 0 0 1.50
William Demant Competitors 126 702 1249 52 2.58

As a group, “Surgical appliances & supplies” companies have a potential upside of 4.86%. Given William Demant’s competitors stronger consensus rating and higher probable upside, analysts clearly believe William Demant has less favorable growth aspects than its competitors.

Risk and Volatility

William Demant has a beta of 0.44, meaning that its stock price is 56% less volatile than the S&P 500. Comparatively, William Demant’s competitors have a beta of 0.84, meaning that their average stock price is 16% less volatile than the S&P 500.

Earnings and Valuation

This table compares William Demant and its competitors top-line revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
William Demant $1.78 billion $216.80 million 44.63
William Demant Competitors $1.33 billion $194.17 million 22.38

William Demant has higher revenue and earnings than its competitors. William Demant is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Institutional & Insider Ownership

54.5% of shares of all “Surgical appliances & supplies” companies are held by institutional investors. 10.5% of shares of all “Surgical appliances & supplies” companies are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares William Demant and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
William Demant N/A N/A N/A
William Demant Competitors -295.29% -52.73% -18.42%

Summary

William Demant competitors beat William Demant on 7 of the 13 factors compared.

William Demant Company Profile

William Demant Holding A/S, a hearing healthcare company, develops, manufactures, and sells products and equipment designed to aid the people with hearing loss connect and communication primarily in Denmark, rest of Europe, North America, Oceania, Asia, and other countries. Its products include hearing devices and implants; diagnostic instruments; and personal communication systems, such as headsets and solutions for the professional call center and office market, as well as consumer headsets for the gaming and mobile segments. The company was founded in 1904 and is headquartered in Smørum, Denmark.

Receive News & Ratings for William Demant Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for William Demant and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Q1 2018 Earnings Estimate for Shire Issued By SunTrust Banks
Q1 2018 Earnings Estimate for Shire Issued By SunTrust Banks
TMAC Resources  Forecasted to Post Q1 2018 Earnings of $0.05 Per Share
TMAC Resources Forecasted to Post Q1 2018 Earnings of $0.05 Per Share
Financial Analysis: Wolters Kluwer  & Thomson Reuters
Financial Analysis: Wolters Kluwer & Thomson Reuters
Head-To-Head Analysis: National CineMedia  vs. Naspers
Head-To-Head Analysis: National CineMedia vs. Naspers
The Children’s Place  & Its Peers Head-To-Head Analysis
The Children’s Place & Its Peers Head-To-Head Analysis
American Homes 4 Rent  Expected to Post Quarterly Sales of $251.71 Million
American Homes 4 Rent Expected to Post Quarterly Sales of $251.71 Million


Leave a Reply

© 2006-2018 Ticker Report. Google+.